Cas:2856-81-7 4-(3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-2-yl)-1-(4-fluorophenyl)butan-1-one manufacturer & supplier

Chemical Name:4-(3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-2-yl)-1-(4-fluorophenyl)butan-1-one

CAS.NO:2856-81-7

Synonyms:Azabuperona [INN-Spanish];Azabuperonum;1-(4-fluoro-phenyl)-4-(hexahydro-pyrrolo[1,2-a]pyrazin-2-yl)-butan-1-one;Azabuperonum [INN-Latin];4-(1,4-diazabicyclo[4.3.0]non-4-yl)-4′-fluorobutyrophenone;Azabuperona;Azabuperone

Molecular Formula:C₁₇H₂₃FN₂O

Molecular Weight:290.37600

HS Code:2933990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:418.3ºC at 760mmHg

Density:1.17g/cm3

Index of Refraction:1.571

PSA:23.55000

Exact Mass:290.17900

LogP:2.44440

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Azabuperona [INN-Spanish] chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Azabuperone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Azabuperona Use and application,Azabuperonum technical grade,usp/ep/jp grade.

Related News: ��We are very worried,�� Chuang Shuk-kwan, a health official, said at a news conference on Sunday. ��Everyone should prepare mentally for the possibility that the disease is spreading within the community.�� 4-(3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-2-yl)-1-(4-fluorophenyl)butan-1-one manufacturer It is foreseeable that in the future, the capacity and output of bulk APIs in China will decrease, the supply-demand relationship will be balanced, and prices and profits will gradually return to a more reasonable range. The era of low prices in the past will be gone forever. Individual APIs Varieties may even lose their price competitive advantage and move abroad. 4-(3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-2-yl)-1-(4-fluorophenyl)butan-1-one supplier From the three-month point onward, 84.5% of uMRD patients maintained that deep remission in the blood to the 12-month assessment. These data show the new combo can deliver “very durable remissions” for the vast majority of patients, Tendler said. 4-(3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-2-yl)-1-(4-fluorophenyl)butan-1-one vendor It is foreseeable that in the future, the capacity and output of bulk APIs in China will decrease, the supply-demand relationship will be balanced, and prices and profits will gradually return to a more reasonable range. The era of low prices in the past will be gone forever. Individual APIs Varieties may even lose their price competitive advantage and move abroad. 4-(3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-2-yl)-1-(4-fluorophenyl)butan-1-one factory ��We are very worried,�� Chuang Shuk-kwan, a health official, said at a news conference on Sunday. ��Everyone should prepare mentally for the possibility that the disease is spreading within the community.��